Orgenesis Appoints Finance Veteran Elliot Maltz As Its Chief Financial Officer, Effective September 1, 2023
Portfolio Pulse from Happy Mohamed
Orgenesis Inc. (NASDAQ:ORGS), a global biotech company, has announced the appointment of Elliot Maltz as its new Chief Financial Officer, effective from September 1, 2023. Maltz, who has 16 years of experience in accounting and corporate finance, will succeed Neil Reithinger. Maltz previously served as the CFO of Gelesis, Inc., where he led several fundraising and operational initiatives.
July 13, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The appointment of Elliot Maltz as CFO of Orgenesis Inc. could bring new strategic insights and financial planning expertise to the company, potentially impacting its financial performance and stock price.
Elliot Maltz's extensive experience in corporate finance and his previous role as CFO of Gelesis, Inc., where he led several fundraising and operational initiatives, could bring valuable insights to Orgenesis Inc. This could potentially lead to improved financial performance and a positive impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100